June 3 (Reuters) - Agenus Inc AGEN.O:
AGENUS AND ZYDUS LIFESCIENCES ENTER $141M STRATEGIC COLLABORATION TO ADVANCE BOT/BAL, EXPAND ZYDUS’ BIOLOGICS MANUFACTURING IN THE US
AGENUS INC: $75M UPFRONT PAYMENT TO AGENUS FOR TRANSFER OF MANUFACTURING ASSETS
AGENUS: ZYDUS TO MAKE A STRATEGIC EQUITY INVESTMENT IN AGENUS BY PURCHASING ABOUT 2.1 MILLION SHARES OF COMMON STOCK AT $7.50 PER SHARE
Source text: ID:nBw8lBB9Sa
Further company coverage: AGEN.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.